Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Emerging Growth Patterns Driving Expansion in the Chemotherapy Induced Peripheral Neuropathy Treatment Market
5+ mon, 3+ day ago (62+ words) openPR.com Emerging Growth Patterns Driving Expansion in the Chemotherapy Induced Peripheral Neuropathy Treatment Market Press release from: The Business Research Company Permanent link to this press release: You can edit or delete your press release Emerging Growth Patterns Driving…...
Study shows new drug compounds dial down inflammation without compromising immunity
5+ mon, 1+ week ago (49+ words) [IMAGE] EurekAlert! ENDOtollins inhibit Munc13-4-Syntaxin 7 binding and decrease endosomal TLR activation. Can be used with related coverage and with credit More on this News Release Study shows new drug compounds dial down inflammation without compromising immunity...
$37 Bn Rheumatoid Arthritis Drugs Markets, 2026-2036: Opportunities in Emerging JAK Inhibitors, Technological Advancements, and Increasing Organic Strategies Among Market Players
6+ mon, 3+ week ago (283+ words) How is the Rheumatoid Arthritis market evolving? What is driving and restraining the Rheumatoid Arthritis market? How will each Rheumatoid Arthritis submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2036? How will…...
Lestter Cruz Serrano: Glad to be included on the list of Authentic Voices in Medicine - OncoDaily
7+ mon, 2+ week ago (225+ words) Lestter Cruz Serrano, Head of Global Medical Affairs, Board Member, HCP and KOL Engagement, Digital Health Innovation, Medical, AI Strategy Leader shared a post by Robert L., Sales and Marketing Thought Leader, Intersectional Strategist, on LinkedIn, adding: “Glad to be included…...
A Drug-Free Answer to Chronic Pain Makes Its Debut at CES 2026
8+ mon, 4+ hour ago (208+ words) Driven by growing global demand for anti-aging, lifting, and tightening solutions, WONTECH continues to expand exports across Asia, Europe, the Middle East, and South America, serving domestic distributors and medical institutions as well as international markets. Wontech Ellise CES 2026 JOPLIN,…...
Evaluating Cost-Effectiveness of Subcutaneous Methotrexate for RA
9+ mon, 3+ day ago (861+ words) In the realm of chronic inflammatory diseases, rheumatoid arthritis (RA) stands out as a formidable adversary, affecting millions worldwide with its debilitating effects. Patients suffering from RA often seek effective treatment options that not only alleviate symptoms but also offer…...
SGLT2 inhibitors for diabetes may protect against autoimmune rheumatic diseases
9+ mon, 1+ week ago (321+ words) CHICAGO — Patients with type 2 diabetes who received sodium-glucose cotransporter-2 inhibitors had a lower risk for rheumatic disease vs. those who received dipeptidyl peptidase-4 inhibitors, according to a speaker at ACR Convergence 2025. “Treatment with dipeptidyl peptidase-4 (DPP-4) inhibitors have been shown…...
GLP-1RA Therapy Linked to Lower Incidence of Rheumatic Diseases
10+ mon, 1+ week ago (334+ words) CHICAGO — Glucagon-like peptide-1 receptor agonist (GLP-1RA) use is associated with a reduced risk of developing rheumatoid arthritis (RA), gout, and osteoarthritis (OA), according to study results presented at the American College of Rheumatology (ACR) Convergence 2025, held in Chicago, Illinois, from…...
Tapering Methotrexate Is Feasible in Stable RA With Careful Monitoring
10+ mon, 2+ week ago (308+ words) Among patients with well-controlled rheumatoid arthritis (RA), tapering or stopping methotrexate (MTX) doesn’t increase the risk for flares over the long term, according to study results presented at the American College of Rheumatology (ACR) Convergence 2025, held from October 24 to 29, in…...
Cyclana Bio raises £5M to advance drug discovery for endometriosis
10+ mon, 3+ week ago (482+ words) Cyclana Bio, a biotechnology company pioneering tissue-level approaches to women's health, today announced the close of a £5M pre-seed funding round, co-led by NfX and Eka VC, and including Cocoa VC, Wilbe, and Angel investors. Cyclana Bio raises £5M to advance drug…...